Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Amarillo Biosciences reaches IFN-alpha development agreement in China

June 24, 1999

Rebetol combination therapy for treatment of chronic HCV launched in Germany

June 22, 1999

Thiourea derivatives of plaunotol with good anti-H. pylori and antiulcer activity

June 21, 1999

Hepatoprotective agents in development at Korean labs

June 17, 1999

Ophidian in the process of expanding clinical development programs

June 10, 1999

New agents for IBS in development at Kyorin

June 10, 1999

Allelix's new treatment for short bowel syndrome advances to phase II

June 10, 1999

Ortho-McNeil presents basic research in the area of motilin antagonists

June 9, 1999

HAV vaccine prevents secondary hepatitis A infection

June 9, 1999

Stem cells provide lineage for liver cells, according to U. of Pittsburgh study

June 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...